You searched for lung cancer | Page 58 of 166

FDA Approves Thermo Fisher CDx for ENHERTU Targeted NSCLC Therapy

ENHERTU is a specifically engineered HER2 directed antibody drug conjugate developed and commercialized by Daiichi Sankyo and AstraZeneca.

KSL Beutner Laboratories (Beutner) has launched an IIF serum blood test in the U.S. that positively identifies laminin 332.

Posted by Andy Lundin | Aug 1, 2022 | Cancer |

The Alliance for Clinical Trials in Oncology announced a new study that aims to assess the utility of early cancer detection blood tests.

Posted by Andy Lundin | Jul 20, 2022 | Cancer |

A key genetic mutation that occurs early on in cancer alters RNA “dark matter” and causes the release of RNA biomarkers for cancer detection.

Posted by Andy Lundin | Jul 18, 2022 | Cancer |

A research lab reported using chaperonin as a new marker for cancer cells in blood that provides a clearer indication of spreading cancer.